Article Information
History
- February 3, 2021.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Chadi M. Saad-Roy1,*,
- Sinead E. Morris5,
- C. Jessica E. Metcalf2,3,
- Michael J. Mina6,
- Rachel E. Baker2,4,
- Jeremy Farrar7,
- Edward C. Holmes8,
- Oliver G. Pybus9,
- Andrea L. Graham2,
- Simon A. Levin2,
- Bryan T. Grenfell2,3,10,* and
- Caroline E. Wagner11,*
- 1Lewis-Sigler Institute for Integrative Genomics, Princeton NJ 08540, USA
- 2Department of Ecology and Evolutionary Biology, Princeton NJ 08540, USA
- 3Princeton School of Public and International Affairs, Princeton NJ 08540, USA
- 4Princeton Environmental Institute, Princeton University, Princeton NJ 08540, USA
- 5Department of Pathology and Cell Biology, Columbia University Medical Center, New York NY 10032, USA
- 6Departments of Epidemiology and Immunology and Infectious Diseases, Harvard School of Public Health, Boston MA 02115, USA
- 7The Wellcome Trust, London, UK
- 8Marie Bashir Institute for Infectious Diseases and Biosecurity, School of Life and Environmental Sciences and School of Medical Sciences, The University of Sydney, Sydney, NSW, Australia
- 9Department of Zoology, University of Oxford, Oxford, UK
- 10Fogarty International Center, National Institutes of Health, Bethesda MD 20892, USA
- 11Department of Bioengineering, McGill University, Montreal QC H3A 0C3, Canada
- ↵*To whom correspondence should be addressed; csaadroy{at}princeton.edu (CMSR); grenfell{at}princeton.edu (BTG); caroline.wagner{at}mcgill.ca (CEW)
Posted February 03, 2021.
Epidemiological and evolutionary considerations of SARS-CoV-2 vaccine dosing regimes
